Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Mulet

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Biomedicines|September 28, 2021
Immunological Status of Bladder Cancer Patients Based on Urine Leukocyte Composition at Radical CystectomyElisabet Cantó, Óscar Rodríguez Faba, Carlos Zamora, et al.
Pharmaceutics|October 29, 2025
Non-Competitive Binding of Isatuximab and Daratumumab to CD38: Implications for Targeted Therapy in Multiple MyelomaRubén Osuna-Gómez, Jordi López-Pardo, Maria Mulet, et al.
Cancers|May 11, 2024
Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 InhibitorsLeticia Alserawan, Maria Mulet, Geòrgia Anguera, et al.
Scientific Reports|March 1, 2019
Migrated T lymphocytes into malignant pleural effusions: an indicator of good prognosis in lung adenocarcinoma patientsJuan C Nieto, Carlos Zamora, José M Porcel, et al.
Immunology|October 23, 2022
The immunoregulatory role of IL-35 in patients with interstitial lung diseaseRubén Osuna-Gómez, Silvia Barril, Maria Mulet, et al.
Cancers|May 28, 2022
Influence of Malignant Pleural Fluid from Lung Adenocarcinoma Patients on Neutrophil ResponseMaria Mulet, Rubén Osuna-Gómez, Carlos Zamora, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2022
The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agentsCarlos Zamora Atenza, Geòrgia Anguera, Mariona Riudavets Melià, et al.
British Journal of Haematology|September 27, 2024
Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patientsRubén Osuna-Gómez, Carlos Zamora, Silvana Novelli, et al.
Cells|May 13, 2025
Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid ArthritisCarlos Zamora, Cesar Diaz-Torne, Maria Angels Ortiz, et al.
Immunology|June 29, 2023
Dysregulated neutrophil extracellular traps formation in sepsisMaria Mulet, Ruben Osuna-Gómez, Carlos Zamora, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Biomedicines|September 28, 2021
Immunological Status of Bladder Cancer Patients Based on Urine Leukocyte Composition at Radical CystectomyElisabet Cantó, Óscar Rodríguez Faba, Carlos Zamora, et al.
Pharmaceutics|October 29, 2025
Non-Competitive Binding of Isatuximab and Daratumumab to CD38: Implications for Targeted Therapy in Multiple MyelomaRubén Osuna-Gómez, Jordi López-Pardo, Maria Mulet, et al.
Cancers|May 11, 2024
Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 InhibitorsLeticia Alserawan, Maria Mulet, Geòrgia Anguera, et al.
Scientific Reports|March 1, 2019
Migrated T lymphocytes into malignant pleural effusions: an indicator of good prognosis in lung adenocarcinoma patientsJuan C Nieto, Carlos Zamora, José M Porcel, et al.
Immunology|October 23, 2022
The immunoregulatory role of IL-35 in patients with interstitial lung diseaseRubén Osuna-Gómez, Silvia Barril, Maria Mulet, et al.
Cancers|May 28, 2022
Influence of Malignant Pleural Fluid from Lung Adenocarcinoma Patients on Neutrophil ResponseMaria Mulet, Rubén Osuna-Gómez, Carlos Zamora, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2022
The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agentsCarlos Zamora Atenza, Geòrgia Anguera, Mariona Riudavets Melià, et al.
British Journal of Haematology|September 27, 2024
Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patientsRubén Osuna-Gómez, Carlos Zamora, Silvana Novelli, et al.
Cells|May 13, 2025
Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid ArthritisCarlos Zamora, Cesar Diaz-Torne, Maria Angels Ortiz, et al.
Immunology|June 29, 2023
Dysregulated neutrophil extracellular traps formation in sepsisMaria Mulet, Ruben Osuna-Gómez, Carlos Zamora, et al.
Pageof 3